Annual Total Expenses
$133.59 M
+$20.43 M+18.05%
December 31, 2023
Summary
- As of February 26, 2025, FDMT annual total expenses is $133.59 million, with the most recent change of +$20.43 million (+18.05%) on December 31, 2023.
- During the last 3 years, FDMT annual total expenses has risen by +$63.31 million (+90.09%).
- FDMT annual total expenses is now at all-time high.
Performance
FDMT Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Expenses
$51.13 M
+$8.67 M+20.43%
September 30, 2024
Summary
- As of February 26, 2025, FDMT quarterly total expenses is $51.13 million, with the most recent change of +$8.67 million (+20.43%) on September 30, 2024.
- Over the past year, FDMT quarterly total expenses has increased by +$16.96 million (+49.61%).
- FDMT quarterly total expenses is now at all-time high.
Performance
FDMT Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
FDMT Total Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +18.1% | +49.6% |
| 3 y3 years | +90.1% | +49.6% |
| 5 y5 years | +444.6% | +49.6% |
FDMT Total Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +49.5% | at high | +105.7% |
| 5 y | 5-year | at high | +153.9% | at high | +235.6% |
| alltime | all time | at high | +683.0% | at high | +311.5% |
4D Molecular Therapeutics Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $51.13 M(+20.4%) |
| Jun 2024 | - | $42.46 M(+11.3%) |
| Mar 2024 | - | $38.16 M(+4.2%) |
| Dec 2023 | $133.59 M(+18.1%) | $36.63 M(+7.2%) |
| Sep 2023 | - | $34.18 M(+5.6%) |
| Jun 2023 | - | $32.38 M(+6.5%) |
| Mar 2023 | - | $30.40 M(+1.5%) |
| Dec 2022 | $113.16 M(+26.6%) | $29.97 M(+11.0%) |
| Sep 2022 | - | $27.00 M(-5.6%) |
| Jun 2022 | - | $28.59 M(+3.5%) |
| Mar 2022 | - | $27.61 M(+11.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $89.37 M(+27.2%) | $24.86 M(+3.5%) |
| Sep 2021 | - | $24.03 M(+8.3%) |
| Jun 2021 | - | $22.18 M(+21.1%) |
| Mar 2021 | - | $18.31 M(-5.8%) |
| Dec 2020 | $70.28 M(+33.6%) | $19.45 M(+27.6%) |
| Sep 2020 | - | $15.24 M(-18.9%) |
| Jun 2020 | - | $18.78 M(+11.7%) |
| Mar 2020 | - | $16.81 M(-8.2%) |
| Dec 2019 | $52.61 M(+114.5%) | $18.32 M(+47.4%) |
| Sep 2019 | - | $12.43 M |
| Dec 2018 | $24.53 M(+43.8%) | - |
| Dec 2017 | $17.06 M | - |
FAQ
- What is 4D Molecular Therapeutics annual total expenses?
- What is the all time high annual total expenses for 4D Molecular Therapeutics?
- What is 4D Molecular Therapeutics annual total expenses year-on-year change?
- What is 4D Molecular Therapeutics quarterly total expenses?
- What is the all time high quarterly total expenses for 4D Molecular Therapeutics?
- What is 4D Molecular Therapeutics quarterly total expenses year-on-year change?
What is 4D Molecular Therapeutics annual total expenses?
The current annual total expenses of FDMT is $133.59 M
What is the all time high annual total expenses for 4D Molecular Therapeutics?
4D Molecular Therapeutics all-time high annual total expenses is $133.59 M
What is 4D Molecular Therapeutics annual total expenses year-on-year change?
Over the past year, FDMT annual total expenses has changed by +$20.43 M (+18.05%)
What is 4D Molecular Therapeutics quarterly total expenses?
The current quarterly total expenses of FDMT is $51.13 M
What is the all time high quarterly total expenses for 4D Molecular Therapeutics?
4D Molecular Therapeutics all-time high quarterly total expenses is $51.13 M
What is 4D Molecular Therapeutics quarterly total expenses year-on-year change?
Over the past year, FDMT quarterly total expenses has changed by +$16.96 M (+49.61%)